[{"Assets_0_Q1_USD":1068467000.0,"CommonStockSharesOutstanding_0_Q1_shares":49808692.0,"EarningsPerShareBasic_1_Q1_USD":-0.1,"EarningsPerShareDiluted_1_Q1_USD":-0.1,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-991000.0,"NetIncomeLoss_1_Q1_USD":-4908000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":117814000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":49580089.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":49580089.0,"Ticker":"EBS","CIK":"1367644","name":"EMERGENT BIOSOLUTIONS INC.","OfficialName":"Emergent Biosolutions Inc. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2077670312.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20180504"}]